highly significantp<0.001
The primary analysis using repeated-measures ANOVA demonstrated a highly significant overall treatment effect for HbA1c (p<0.001), indicating distinct patterns of glycemic changes between the groups.
The primary analysis using repeated-measures ANOVA demonstrated a highly significant overall treatment effect for HbA1c (p<0.001), indicating distinct patterns of glycemic changes between the groups.
Notably, while within-group improvements in %B ( Figure 3 ) and BMI ( Figure 4 ) were observed in the Del-Immune group (p<0.05), these did not reach statistical significance when compared directly to the placebo group.